Temozolomide

FDA Approved: * March 1, 2010
Pharm Company: * BARR
Category: Cancer

Temozolomide (TMZ), sold under the brand name Temodar among others, is a medication used to treat some brain tumors such as glioblastoma multiforme or anaplastic astrocytoma.[3][4] It is taken by mouth or via intravenous infusion.[3][4] The most common side effects with temozolomide are nausea, vomiting, constipation, loss of appetite, alopecia (hair loss), headache, fatigue, convulsions (seizures), rash, neutropenia or lymphopen... [wikipedia]

* May have multiple approval dates, manufacturers, or labelers.
1 Discussion

Dosage List

Temozolomide 5 mg Oral Capsule
NDC: 0054-0320
Labeler:
Roxane Laboratories, Inc.
Temozolomide 20 mg Oral Capsule
NDC: 0054-0321
Labeler:
Roxane Laboratories, Inc.
Temozolomide 100 mg Oral Capsule
NDC: 0054-0322
Labeler:
Roxane Laboratories, Inc.
Temozolomide 140 mg Oral Capsule
NDC: 0054-0323
Labeler:
Roxane Laboratories, Inc.
Temozolomide 180 mg Oral Capsule
NDC: 0054-0324
Labeler:
Roxane Laboratories, Inc.
Temozolomide 250 mg Oral Capsule
NDC: 0054-0325
Labeler:
Roxane Laboratories, Inc.
Temozolomide 5 mg Oral Capsule
NDC: 0093-7599
Labeler:
Teva Pharmaceuticals USA Inc
Temozolomide 20 mg Oral Capsule
NDC: 0093-7600
Labeler:
Teva Pharmaceuticals USA Inc
Temozolomide 100 mg Oral Capsule
NDC: 0093-7601
Labeler:
Teva Pharmaceuticals USA Inc
Temozolomide 250 mg Oral Capsule
NDC: 0093-7602
Labeler:
Teva Pharmaceuticals USA Inc

Related Brands

Drugs with the same active ingredients

Popular Topics

Temozolomide

Please be as detailed as possible...